Effect of the STRIDE fall injury prevention intervention on falls, fall injuries, and health-related quality of life.
care management
falls
health-related quality of life
older persons
pragmatic trials
Journal
Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
revised:
29
05
2022
received:
14
05
2022
accepted:
05
06
2022
pubmed:
7
8
2022
medline:
15
11
2022
entrez:
6
8
2022
Statut:
ppublish
Résumé
Falls are common in older adults and can lead to severe injuries. The Strategies to Reduce Injuries and Develop Confidence in Elders (STRIDE) trial cluster-randomized 86 primary care practices across 10 health systems to a multifactorial intervention to prevent fall injuries, delivered by registered nurses trained as falls care managers, or enhanced usual care. STRIDE enrolled 5451 community-dwelling older adults age ≥70 at increased fall injury risk. We assessed fall-related outcomes via telephone interviews of participants (or proxies) every 4 months. At baseline, 12 and 24 months, we assessed health-related quality of life (HRQOL) using the EQ-5D-5L and EQ-VAS. We used Poisson models to assess intervention effects on falls, fall-related fractures, fall injuries leading to hospital admission, and fall injuries leading to medical attention. We used hierarchical longitudinal linear models to assess HRQOL. For recurrent event models, intervention versus control incidence rate ratios were 0.97 (95% confidence interval [CI], 0.93-1.00; p = 0.048) for falls, 0.93 (95% CI, 0.80-1.08; p = 0.337) for self-reported fractures, 0.89 (95% CI, 0.73-1.07; p = 0.205) for adjudicated fractures, 0.91 (95% CI, 0.77-1.07; p = 0.263) for falls leading to hospital admission, and 0.97 (95% CI, 0.89-1.06; p = 0.477) for falls leading to medical attention. Similar effect sizes (non-significant) were obtained for dichotomous outcomes (e.g., participants with ≥1 events). The difference in least square mean change over time in EQ-5D-5L (intervention minus control) was 0.009 (95% CI, -0.002 to 0.019; p = 0.106) at 12 months and 0.005 (95% CI, -0.006 to 0.015; p = 0.384) at 24 months. Across a standard set of outcomes typically reported in fall prevention studies, we observed modest improvements, one of which was statistically significant. Future work should focus on patient-, practice-, and organization-level operational strategies to increase the real-world effectiveness of interventions, and improving the ability to detect small but potentially meaningful clinical effects. gov identifier: NCT02475850.
Sections du résumé
BACKGROUND
Falls are common in older adults and can lead to severe injuries. The Strategies to Reduce Injuries and Develop Confidence in Elders (STRIDE) trial cluster-randomized 86 primary care practices across 10 health systems to a multifactorial intervention to prevent fall injuries, delivered by registered nurses trained as falls care managers, or enhanced usual care. STRIDE enrolled 5451 community-dwelling older adults age ≥70 at increased fall injury risk.
METHODS
We assessed fall-related outcomes via telephone interviews of participants (or proxies) every 4 months. At baseline, 12 and 24 months, we assessed health-related quality of life (HRQOL) using the EQ-5D-5L and EQ-VAS. We used Poisson models to assess intervention effects on falls, fall-related fractures, fall injuries leading to hospital admission, and fall injuries leading to medical attention. We used hierarchical longitudinal linear models to assess HRQOL.
RESULTS
For recurrent event models, intervention versus control incidence rate ratios were 0.97 (95% confidence interval [CI], 0.93-1.00; p = 0.048) for falls, 0.93 (95% CI, 0.80-1.08; p = 0.337) for self-reported fractures, 0.89 (95% CI, 0.73-1.07; p = 0.205) for adjudicated fractures, 0.91 (95% CI, 0.77-1.07; p = 0.263) for falls leading to hospital admission, and 0.97 (95% CI, 0.89-1.06; p = 0.477) for falls leading to medical attention. Similar effect sizes (non-significant) were obtained for dichotomous outcomes (e.g., participants with ≥1 events). The difference in least square mean change over time in EQ-5D-5L (intervention minus control) was 0.009 (95% CI, -0.002 to 0.019; p = 0.106) at 12 months and 0.005 (95% CI, -0.006 to 0.015; p = 0.384) at 24 months.
CONCLUSIONS
Across a standard set of outcomes typically reported in fall prevention studies, we observed modest improvements, one of which was statistically significant. Future work should focus on patient-, practice-, and organization-level operational strategies to increase the real-world effectiveness of interventions, and improving the ability to detect small but potentially meaningful clinical effects.
CLINICALTRIALS
gov identifier: NCT02475850.
Identifiants
pubmed: 35932279
doi: 10.1111/jgs.17964
pmc: PMC9669115
mid: NIHMS1822538
doi:
Banques de données
ClinicalTrials.gov
['NCT02475850']
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3221-3229Subventions
Organisme : NIA NIH HHS
ID : P30 AG028747
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG024824
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG021342
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000142
Pays : United States
Organisme : Patient-Centered Outcomes Research Institute
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG024832
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG024827
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG048270
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG031679
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000114
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR000113
Pays : United States
Informations de copyright
© 2022 Wiley Periodicals LLC. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.
Références
N Engl J Med. 2020 Jul 9;383(2):129-140
pubmed: 32640131
Value Health. 2019 Aug;22(8):931-941
pubmed: 31426935
BMJ. 2021 Apr 6;373:n740
pubmed: 33824131
Cochrane Database Syst Rev. 2018 Jul 23;7:CD012221
pubmed: 30035305
Value Health. 2018 Sep;21(9):1090-1097
pubmed: 30224114
Am J Epidemiol. 2011 Oct 15;174(8):984-92
pubmed: 21841157
Inj Epidemiol. 2019 Apr 15;6:14
pubmed: 31245263
Age Ageing. 2007 Nov;36(6):656-62
pubmed: 18056731
N Engl J Med. 2020 Nov 5;383(19):1848-1859
pubmed: 33211928
Respir Care. 2015 Jan;60(1):88-95
pubmed: 25336531
Stat Med. 2021 Feb 28;40(5):1306-1320
pubmed: 33316841
N Engl J Med. 2008 Jul 17;359(3):252-61
pubmed: 18635430
Clin Trials. 2021 Apr;18(2):207-214
pubmed: 33678038
J Am Geriatr Soc. 2020 Jun;68(6):1242-1249
pubmed: 32212395
Cochrane Database Syst Rev. 2019 Jan 31;1:CD012424
pubmed: 30703272
J Gerontol A Biol Sci Med Sci. 2018 Oct 8;73(11):1495-1501
pubmed: 30020415
N Engl J Med. 2020 Feb 20;382(8):734-743
pubmed: 32074420
J Am Geriatr Soc. 2017 Dec;65(12):2733-2739
pubmed: 29044479
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
J Am Geriatr Soc. 2021 Jan;69(1):173-179
pubmed: 33037632
J Am Geriatr Soc. 2021 May;69(5):1334-1342
pubmed: 33580718
J Am Geriatr Soc. 2005 Sep;53(9):1618-22
pubmed: 16137297
Health Technol Assess. 2021 May;25(34):1-114
pubmed: 34075875
J Gerontol A Biol Sci Med Sci. 2018 Jul 9;73(8):1053-1061
pubmed: 29045582